IPO Calendar Three Companies Set to Launch Public Offers Amid Market Volatility Ferrari Luce EV Launch Sparks Controversy Shares Drop Nearly 8 on Design Criticism Why the Cost of Everyday Essentials Has Surged The Case of Eggs Conservative Crypto Options for RiskAware Investors Gain Attention Department of Energy Highlights Progress in PlugIn Electric Vehicle and Battery Technology London Stock Exchange Group Reports Income Growth Driven by Tradeweb Performance Quantum Biopharma Ltd Q4 2025 Earnings Narrowing Loss Amid Strategic Pipeline Advances Cytokinetics Q1 2026 Earnings Narrowed Loss Beats Estimates as Pipeline Progress Takes Center Stage DMRA Q1 2026 Earnings WiderthanExpected Loss but Stock Gains Amid Pipeline Optimism POWI Q1 2026 Earnings EPS Surpasses Estimates Amid Revenue Uncertainty STRK Q1 2026 Earnings Preferred Stock Reports Deep EPS Shortfall as Revenue Remains Undisclosed SCLX Q1 2026 Earnings Net Loss Widens as Pipeline Progress Drives Stock Higher Black Hawk Acquisition Corporation Units BKHAU Price Steady at 1190 as SPAC Market Scrutiny Continues CEA Industries Warrant BNCWW Holds Steady at 003 Amid Flat Trading Liberty Broadband Preferred Stock LBRDP Edges Higher Testing Resistance Near 2311 Dime Community Bancshares Subordinated Notes DCOMG Hold Steady at 2585 Amid Flat Trading Session Apple Hospitality REIT Holds Steady Near 1480 as Support Levels Tighten Pinterest Inc Analyst Report Suggests Potential Growth Amid Digital Ad Shifts ENTA Q1 2026 Earnings Narrowed Loss Beats Expectations Stock Slips as Investors Await Pipeline Progress Eureka Acquisition Corp EURK Holds Steady at 115 Navigating a Neutral Channel MaxCyte Inc MXCT Surges 787 as Shares Test Key Resistance Level Amcor AMCR Surges Over 2 as Support Holds Approaching Key Resistance AiRWA Inc YYAI Holds Ground Near Support After Minor Dip Meridian Holdings Inc MRDN Gains 164 as Price Approaches Key Resistance Honest Company HNST Rallies 47 as Shares Approach Key Resistance Level WaterBridge Infrastructure WBI Faces Pressure Price Drops Nearly 5 BristolMyers Squibb BMY Sees Modest Decline Holds Above Key Support